It is worth mentioning that China's FDA said that the application for a marketing license for LIR injection for obesity or overweight indications had been accepted, which was the first time that the weight control indications of GLP-1R agonists have been accepted in China
Activation of glucagon-like peptide-I receptors in the nucleus accumbens attenuates cocaine seeking in rats
GLP-1 Market Overview 2025 GLP-1 Market Overview 2025 Amid rapid market growth, this report examines the evolving GLP-1 supply landscape, drawing on QYOBOs visibility into global manufacturing, regulatory activity, and pricing trends
Wegovy (also semaglutide) carries the obesity indication and may be covered under the CMS GLP-1 Bridge Program starting July 2026
Ipamorelin is packaged in a sealed laboratory vial designed to help maintain product integrity during shipping and storage
Start Your Assessment Deep Dive: Detailed Cost Profiles of the Top 8 Competitors To help you compare the market objectively, we have analyzed the billing structures, dosage policies, and onboarding programs of the top eight telehealth providers offering semaglutide online in 2026